Mayu Yagita
Overview
Explore the profile of Mayu Yagita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
94
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomofuji Y, Kishikawa T, Maeda Y, Ogawa K, Otake-Kasamoto Y, Kawabata S, et al.
Cell Genom
. 2023 Feb;
2(12):100219.
PMID: 36778050
We reconstructed 19,084 prokaryotic and 31,395 viral genomes from 787 Japanese gut metagenomes as Japanese metagenome-assembled genomes (JMAG) and Japanese Virus Database (JVD), which are large microbial genome datasets for...
2.
Otsuka T, Nishida S, Shibahara T, Temizoz B, Hamaguchi M, Shiroyama T, et al.
BMC Cancer
. 2022 Jul;
22(1):744.
PMID: 35799134
Background: Cytosine-phosphate-guanine oligodeoxynucleotide (CpG ODN) (K3)-a novel synthetic single-stranded DNA immune adjuvant for cancer immunotherapy-induces a potential Th1-type immune response against cancer cells. We conducted a phase I study of...
3.
Nishide M, Yagita M, Kumanogoh A
Biologics
. 2022 Apr;
16:17-19.
PMID: 35386275
TNF-alpha-targeted therapies during pregnancy is a topic of interest in rheumatology. Etanercept (ETN) is expected to have lower transplacental transfer, however, clinical evidence is lacking on the usefulness and safeness...
4.
Yagita M, Morita T, Kumanogoh A
Rheumatol Adv Pract
. 2022 Jan;
5(3):rkab099.
PMID: 34988358
Objectives: Denosumab is used for osteoporosis because it inhibits osteoclast maturation and suppresses bone resorption. Although denosumab is expected to inhibit the bone erosion in RA, its therapeutic efficacy is...
5.
Tomofuji Y, Kishikawa T, Maeda Y, Ogawa K, Nii T, Okuno T, et al.
Ann Rheum Dis
. 2021 Dec;
81(2):278-288.
PMID: 34880054
Objective: The relationship between autoimmune diseases and the gut microbiome has been intensively studied, and several autoimmunity-associated bacterial taxa have been identified. However, much less is known about the roles...
6.
Tomofuji Y, Maeda Y, Oguro-Igashira E, Kishikawa T, Yamamoto K, Sonehara K, et al.
Ann Rheum Dis
. 2021 Aug;
80(12):1575-1583.
PMID: 34426398
Objective: Alteration of the gut microbiome has been linked to the pathogenesis of systemic lupus erythematosus (SLE). However, a comprehensive view of the gut microbiome in SLE and its interaction...
7.
Yamaguchi Y, Maeda Y, Shibahara T, Nameki S, Nakabayashi A, Komuta K, et al.
Mod Rheumatol Case Rep
. 2020 Oct;
4(2):302-309.
PMID: 33087016
TAFRO syndrome is a newly proposed disease that is characterised by thrombocytopenia, anasarca, fever, reticulin fibrosis (or renal dysfunction), and organomegaly. Generally, high doses of corticosteroids are recommended for the...
8.
Yagita M, Hata S, Miyata H, Kakita H, Tsukamoto T, Muso E, et al.
Intern Med
. 2018 Oct;
58(5):731-735.
PMID: 30333422
Systemic lupus erythematosus (SLE) may be associated with various types of malignancy. However, SLE occurring with ovarian cancer seems rare, and reliable therapeutic approaches for such cases have yet to...
9.
Atypical Presenting Symptoms of Acute Onset Systemic Lupus Erythematosus with Enteritis and Cystitis
Yagita M, Tsujimoto K, Yagita M, Fujita M
Case Rep Med
. 2016 Apr;
2016:8579812.
PMID: 27066078
Lupus enteritis and lupus cystitis are relatively rare manifestations of systemic lupus erythematosus. Some patients develop severe complications such as bowel perforation, infarction, obstruction, or irreversible bladder dysfunction. Early diagnosis...